Bengaluru Doctors Unite to Raise Awareness on HPV-Related Cancers

In a significant public health initiative, oncologists and pediatricians gathered in Bengaluru on June 24, 2025, to address the critical need for awareness regarding Human Papillomavirus (HPV) and its association with various cancers. The event, dubbed the 'Conquer HPV and Cancer Conclave 2025,' emphasized that HPV is not limited to cervical cancer but also correlates with vulvar, vaginal, anal, penile, and oropharyngeal cancers, affecting both genders.

Dr. Bhaskar Shenoy, head of the Pediatrics and Pediatric Infectious Diseases Division at Manipal Hospitals, moderated the conclave, during which healthcare professionals highlighted the importance of educating adolescents and parents about HPV. With peak HPV infection rates occurring between the ages of 15 and 25, early awareness and preventive measures are deemed essential.

The conclave is part of a nationwide public health initiative spearheaded by the Serum Institute of India (SII). According to data from the International Agency for Research on Cancer (IARC) in 2023, India sees over 123,000 new cervical cancer cases and approximately 77,000 related deaths annually, making it a pressing public health concern. Additionally, the data indicates that up to 90% of anal cancers and approximately 63% of penile cancers are linked to HPV.

Dr. Sarah Johnson, an Epidemiologist at Johns Hopkins University, emphasized the role of vaccination in combating HPV-related cancers. "With the availability of affordable HPV vaccines, we now have a powerful tool to protect individuals from these cancers," Dr. Johnson stated. This aligns with the findings of a study published in the Journal of Cancer Research (2023), which advocates for widespread vaccination as a critical strategy in cancer prevention.

The conclave is anticipated to continue its efforts across various cities in India, aiming to create platforms for healthcare professionals to educate the public effectively. The SII has committed to supporting these initiatives, reinforcing the need for a collaborative approach to combat the rising rates of HPV-related cancers in the country.

The implications of this initiative extend beyond immediate health concerns, as increased public awareness and vaccination uptake could lead to long-term reductions in cancer incidence and mortality associated with HPV. As public health experts rally to inform and empower communities, the potential for significant advancements in cancer prevention becomes increasingly apparent.

As the initiative unfolds, the healthcare community remains vigilant in its efforts to mitigate the impact of HPV in India. With ongoing support and advocacy, there is hope for a future where HPV-related cancers are significantly reduced, benefiting countless lives across the nation.